Pope Asset Management’s TIANYIN PHARMACEUTICAL TPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $0 | Buy |
+745,175
| New | – | ﹤0.01% | 24 |
|
|
2017
Q4 | $0 | Hold |
745,175
| – | – | ﹤0.01% | 26 |
|
|
2017
Q3 | $0 | Hold |
745,175
| – | – | ﹤0.01% | 26 |
|
|
2017
Q2 | $0 | Hold |
745,175
| – | – | ﹤0.01% | 26 |
|
|
2017
Q1 | $119K | Hold |
745,175
| – | – | 0.08% | 25 |
|
|
2016
Q4 | $119K | Hold |
745,175
| – | – | 0.09% | 24 |
|
|
2016
Q3 | $119K | Buy |
+745,175
| New | +$119K | 0.1% | 22 |
|
|
2016
Q1 | $111K | Hold |
745,175
| – | – | 0.09% | 23 |
|
|
2015
Q4 | $124K | Hold |
745,175
| – | – | 0.1% | 23 |
|
|
2015
Q3 | $335K | Hold |
745,175
| – | – | 0.21% | 25 |
|
|
2015
Q2 | $348K | Hold |
745,175
| – | – | 0.28% | 19 |
|
|
2015
Q1 | $335K | Hold |
745,175
| – | – | 0.29% | 19 |
|
|
2014
Q4 | $544K | Sell |
745,175
-42,225
| -5% | -$23.1K | 0.44% | 17 |
|
|
2014
Q3 | $504K | Sell |
787,400
-803,269
| -50% | -$508K | 0.3% | 18 |
|
|
2014
Q2 | $1.15M | Sell |
1,590,669
-694,231
| -30% | -$549K | 0.65% | 16 |
|
|
2014
Q1 | $2.24M | Sell |
2,284,900
-2,872,758
| -56% | -$2.88M | 1.29% | 12 |
|
|
2013
Q4 | $4.08M | Sell |
5,157,658
-142,350
| -3% | -$131K | 5.65% | 5 |
|
|
2013
Q3 | $3.98M | Buy |
5,300,008
+2,000
| +0% | +$1.32K | 5.63% | 5 |
|
|
2013
Q2 | $2.61M | Buy |
+5,298,008
| New | +$3.12M | 4.33% | 6 |
|
Pope Asset Management's TPI Position: Q3 2018 in Review
Pope Asset Management opened a new position in TIANYIN PHARMACEUTICAL (TPI) in Q3 2018: 745,175 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #24 among its holdings. This is a return to the name: Pope Asset Management previously reported a position in TPI as recently as Q4 2017.
Pope Asset Management first reported a position in TPI in Q2 2013 and has held it in 19 quarters since. The position peaked at $4.08M in Q4 2013. 1 fund tracked by Wall St. Rank holds TPI as of Q3 2018.
- Pope Asset Management held 745,175 shares of TIANYIN PHARMACEUTICAL worth $0 as of Q3 2018.
- TIANYIN PHARMACEUTICAL was a new Pope Asset Management position in Q3 2018.
- TIANYIN PHARMACEUTICAL made up ﹤0.01% of Pope Asset Management's portfolio in Q3 2018, its #24 holding.
- Pope Asset Management first reported a position in TIANYIN PHARMACEUTICAL in Q2 2013 and has held it in 19 quarters since.
- Pope Asset Management's TIANYIN PHARMACEUTICAL position peaked at $4.08M in Q4 2013.
- 1 fund tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q3 2018.
Based on Pope Asset Management's 13F filing for Q3 2018, filed 30 Nov 2018.